Ascendis Pharma A/S - ADR
ASND
Market Cap$11.76B
Close$
$158.03
23.3% downside
Current Fair Value
23.3% downsideOvervalued by 23.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.76 Billion |
|---|---|
| Enterprise Value | $12.10 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-6.53 |
| Beta | 0.4 |
| Outstanding Shares | 60,454,589 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -37.07 |
|---|---|
| PEG | 57.33 |
| Price to Sales | 25.74 |
| Price to Book Ratio | -51.48 |
| Enterprise Value to Revenue | 24.65 |
| Enterprise Value to EBIT | -72.88 |
| Enterprise Value to Net Income | -45 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | -4.48 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ascendis Pharma A/S
CEO: Jan Moeller Mikkelsen